Rank #1465PLSE

Pulse Biosciences, Inc

$25.08

-1.47% (Daily)

Market Cap

$1.70B

Revenue

$86.00K

Rank by MCap

#1465

Sector

Healthcare

Industry

Medical Instruments & Supplies

CEO

Mr. Paul Arthur LaViolette

Headquarters

Miami, FL

Employees

About Pulse Biosciences, Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; CellFX nsPFA Percutaneous Electrode system for soft tissue ablation in surgical setting; CellFX nsPFA Cardiac Clamp designed for use in surgical treatment of atrial fibrillation (AF); CellFX nsPFA 360° Cardiac Catheter designed to provide a circumferential, or circular, ablation in a single treatment ...